Glossy strategic plan hits the streets
Article Abstract:
The National Institutes of Health (NIH) has published a strategic plan that the agency intends to use to guide its future progress. The plan document is titled 'Investment for Humanity' and identifies six major areas of focus for the NIH. Funding and support for the strategic plan is uncertain.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Childhood vaccines: the R&D factor
Article Abstract:
The Clinton Administration is considering 'universal purchase' of vaccines for children. Vaccine manufacturers maintain that their research and development efforts would suffer if the federal government becomes the only entity buying childhood vaccines.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Center for the mind pleases the senses
Article Abstract:
The Neurosciences Institute, the brainchild of Nobel Prizewinner Gerald Edelman, opened its new $16 million facility on Oct 15, 1995. Funded primarily by the Neurosciences Research Foundation, the institute houses 32 full-time, fully funded researchers.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Derivatives: not the real thing. Yesterday the peso, tomorrow the dollar? Clipper runs aground
- Abstracts: Bromley's last stand. Hughes' tough stand on industry ties. Will the real journal please stand up?
- Abstracts: Catching the wave of a new accelerator. Candid cameras for the nanoworld. New laser serves red light, straight up
- Abstracts: Debating the future of Gwaii Hanaas. Getting their act together. Decision time on the Tashenshini
- Abstracts: Probing the unsolved mysteries of the deep. Physics festival brightens rainy San Jose. Novel anticancer agents move closer to reality